A double-blind, placebo-controlled trial of topiramate for pathological gambling

@article{Berlin2013ADP,
  title={A double-blind, placebo-controlled trial of topiramate for pathological gambling},
  author={Heather A. Berlin and Ashley Braun and Daphne Simeon and Lorrin M. Koran and Marc N. Potenza and Susan L. McElroy and Timothy W. Fong and Stefano Pallanti and Eric Hollander},
  journal={The World Journal of Biological Psychiatry},
  year={2013},
  volume={14},
  pages={121 - 128}
}
Abstract Objectives. Pathological gambling (PG) is an impulse control disorder characterized by recurrent gambling thoughts and behaviours that impair social functioning. Earlier studies suggested that topiramate may be effective in treating some impulse control disorders. We conducted the first randomized, controlled trial of topiramate in PG. Methods. PG patients were randomized to topiramate (N = 20) or placebo (N = 22) in this 14-week, double-blind, placebo-controlled, parallel-group trial… 
View on Taylor & Francis
cviin.s3.amazonaws.com
99 Citations
Highly Influential Citations
6
Background Citations
17
Methods Citations
1
Results Citations
4

99 Citations

Citation Type

Citation Type

Topiramate Combined with Cognitive Restructuring for the Treatment of Gambling Disorder: A Two-Center, Randomized, Double-Blind Clinical Trial
TLDR
It is found that topiramate affects features specifically related to gambling addiction and had no significant effect on associated phenomena such as impulsiveness and depression.
A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topiramate for the Treatment of Compulsive Buying Disorder.
TLDR
The results do not provide support for the use of topiramate in the treatment of CBD and future investigation with larger and representative samples and longer follow-up period are needed.
Meta-analysis: pharmacological treatment of pathological gambling
TLDR
Current trial data provides limited support for the use of any pharmacological agent in the treatment of pathological gambling.
Pharmacological Treatments for Disordered Gambling: A Meta-analysis
TLDR
Results showed that opioid antagonists and mood stabilizers, particularly the glutamatergic agent topiramate combined with a cognitive intervention and lithium for gamblers with bipolar disorders demonstrated promising results, however, more rigorously designed, large-scale randomized controlled trials with extended placebo lead-in periods are necessary.
Pharmacological treatments in pathological gambling
TLDR
Given that several studies have demonstrated their efficacy in treating the symptoms associated with PG, opioid antagonists should be considered the first line treatment for PG at this time.
Pathological Gambling: Neuropsychopharmacology and Treatment.
TLDR
Of medications, the strongest data suggest the efficacy and tolerability of opioid antagonists in the treatment of PG, and other agents have varying degree of empirical support.
Efficacy and safety of topiramate for reducing impulsivity: A transdiagnostic systematic review and meta‐analysis of a common clinical use
TLDR
A systematic review and meta‐analysis of the literature found no clear‐cut evidence for a transdiagnostic effectiveness of topiramate in reducing impulsivity levels, however, encouraging results were found in some specific disorders.
Current pharmacotherapy for gambling disorder: a systematic review
TLDR
Though results are limited, opioid antagonists like naltrexone showed promise in the pharmacological treatment of gambling disorder and pharmacotherapy combined with psychotherapy treatments for gambling disorder may provide better rates of patient retention in comparison to pharmacology-only treatments, though further research is needed.
Discrete Roles for Impulsivity and Compulsivity in Gambling Disorder
TLDR
The findings suggest that specific aspects of impulsivity and compulsivity contribute toGD severity, and interventions specifically targeting domains that are most relevant to GD severity may improve treatment outcomes.
Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features
TLDR
Though off-label, addiction specialists should consider topiramate as a second-line option for drinking reduction in alcohol use disorder, as well as for binge eating disorder or cocaine use disorder.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 87 REFERENCES
Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
TLDR
Olanzapine was not superior to placebo in the short-term treatment of pathological gambling and was also associated with a high discontinuation rate.
Topiramate Versus Fluvoxamine in the Treatment of Pathological Gambling: A Randomized, Blind-Rater Comparison Study
TLDR
The findings support the idea that PG and other disorders of impulse control may be conceptualized as part of the obsessive-compulsive spectrum disorders and topiramate and fluvoxamine monotherapy may be effective in the treatment of pathologic gambling.
A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
TLDR
Subjects assigned to naltrexone demonstrated statistically significant reductions in gambling urges and behavior in PG.
A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling
A pilot study of impulsivity and compulsivity in pathological gambling
A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
TLDR
The results of this trial indicate that paroxetine may be effective in the treatment of pathological gambling, however, additional studies with larger patient samples and a longer treatment phase are required to establish conclusively the efficacy and safety of paroxETine for this indication.
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling
Sertraline treatment of pathological gambling: a pilot study.
TLDR
Sertraline was not statistically significantly superior to placebo in the overall sample, and the power of the study was limited by the high placebo-response rate and the small sample size.
Paroxetine treatment of pathological gambling: a multi‐centre randomized controlled trial
TLDR
High rates of symptom improvement were observed in pathological gamblers receiving either paroxetine or placebo after 16 weeks; however, a larger sample size may have registered significant differences.
...
1
2
3
4
5
...